A free diabetes, endocrinology and medical news article resource for endocrinologists and physicians. Endocrinology conference coverage and drug information.

21 hours ago · Introduction. Amid the soaring use of glucagon-like peptide-1 (GLP-1) drugs for intentional weight loss, a vastly different movement appears to be gaining traction in health …

4 days ago · The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have …

Our drug database contains more than 4000 concise product monographs (OTC & Rx) that can be easily searched by brand name, generic name, and disease

The American Diabetes Association (ADA) has updated its guidelines for the “Standards of Care” for patients with diabetes. The report has been published in Diabetes Care.. In the 2024 …

Jan 2, 2025 · When evaluating under the trial product estimand, findings showed CagriSema-treated patients achieved a superior weight loss of 22.7% compared with 11.8% with …

6 days ago · Among patients who receive endovascular thrombectomy (EVT) for middle cerebral artery (MCA) medium-vessel occlusion (MeVOs), those who have moderate and severe …

Jan 29, 2025 · Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse …

Apr 2, 2024 · Addison’s disease — also referred to as primary adrenal insufficiency — occurs when the adrenal glands do not produce enough cortisol and/or aldosterone, hormones …

Sep 17, 2024 · Type 2 diabetes mellitus is a metabolic disorder characterized by dysregulation of blood glucose caused by relative insulin deficiency and insulin resistance. 1 It is a progressive …